All posts by David Emerson
Sonja’s Story- Non-Hodgkin’s Follicular Lymphoma Diagnosis and Survival
I’ll never forget those words, Sonja you have cancer. Non-Hodgkin’s Follicular Lymphoma. And I was already in stage 4. HOW…? WHY…? BUT THEY SAID… OH MY GOD!!! Sonja Braddock was diagnosed
Continue readingMultiple Myeloma Therapy- Dichloroacetate (DCA)
“The findings of this study shed a new light with respect to some of the novel mechanisms underlying the antitumor action of Dichloroacetate (DCA) and thus may have immense clinical applications.” “It
Continue readingAsk A Multiple Myeloma Survivor
Hi, my name is David Emerson, and I have been a Multiple Myeloma survivor since 1994. To learn the details of my story, please click here. I believe that talking to a Multiple Myeloma survivor about your
Continue readingMultiple Myeloma Diet, Supplementation- A How-To Guide
Many studies confirm that a majority of patients undergoing cancer therapy use non-conventional therapies such as the supplements discussed below: Experience and years of research have taught me that multiple
Continue readingMultiple Myeloma Diagnostics- FISH, SPEP, CBC, FLC’s and Imaging
If you have multiple myeloma your plasma cells produce unhealthy antibodies called monoclonal proteins (M proteins). The accumulation of M proteins in your body can damage organs like your kidneys and
Continue readingCurcumin, Doxorubicin Combo in Relapsed/Refractory Multiple Myeloma
Conclusion: PAd is an active salvage therapy with manageable toxicity in patients with relapsed/refractory multiple myeloma. The good news is that there is a long and growing list of conventional, FDA
Continue readingMultiple Myeloma Diagnosis- Can’t Trust Conventional Cancer Research
You were told that a multiple myeloma diagnosis meant that you could live 5-7 years. Consider thinking outside the conventional therapy box… I received my multiple myeloma diagnosis in early 1994.
Continue readingMultiple Myeloma Chemotherapy – Antioxidants Enhance Action
Much debate has focused on whether antioxidants interfere with the efficacy of cancer chemotherapy. The objective of this study is to systematically review the randomized, controlled clinical trial evidence
Continue readingDCA enhances Velcade in Multiple Myeloma
Dichloracetate (DCA) enhances the efficacy of Velcade, a standard-of-care Multiple Myeloma Therapy Multiple Myeloma (MM) is considered incurable by conventional oncology. In other words, if an MM patient
Continue readingWhite glow? Pink eye? Red eye? Consider Retinoblastoma-
“The longer that retinoblastoma can grow before they’re diagnosed and treated, the more invasive they become” A friend’s daughter was diagnosed with retinoblastoma as an infant.
Continue reading